Biosimilars, a rapidly evolving field in biopharmaceutics, represent a groundbreaking category of therapeutic agents. These biological products, akin to existing biologics, are designed to demonstrate comparable efficacy, safety, and quality. Unlike generic drugs, biosimilars are complex and intricately manufactured, often involving living organisms.
The development of biosimilars is a result of advancements in biotechnology, allowing for the replication of intricate structures found in biopharmaceuticals. These products not only expand patient access to life-changing treatments but also contribute to healthcare affordability.
Biopharmaceutics focuses on understanding the complex interplay between biological systems and pharmaceutical formulations. Biosimilars, being part of this realm, undergo rigorous testing to ensure they meet stringent regulatory standards. As the industry continues to grow, the promise of biosimilars lies in their potential to enhance treatment options, promote competition, and foster innovation in the biopharmaceutical landscape.
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Yong Xiao Wang
Albany Medical College, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Huiqin Yang
ICON Clinical Research Ltd, United KingdomSubmit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Antibody proteases as translational tools of the next step generation to be applied for biopharmacy related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India
Title : Cognitivevoice: Novel machine learning model leveraging acoustic features to predict future cognitive decline in Parkinson’s Disease
Aadya Daga, Hamilton High School, United States
Title : Platelet-activating factor-receptor pathway mediates solar radiation-induced extracellular vesicle release in human keratinocytes
Ravi P Sahu, Wright State University, United States